October 8, 2026 · Platform news · Biological age
What Hub71 and Unilabs Announced
Unilabs Middle East joined the Hub71+ Life Sciences ecosystem as an anchor market partner on 29 September 2026 to expand diagnostics access across Abu Dhabi. Hub71 operates as an Abu Dhabi technology ecosystem that provides commercial adoption pathways for regional startups. The agreement grants early-stage healthcare companies access to diagnostic infrastructure, laboratory expertise, and clinical networks across the Middle East.
On biological age testing, the release confirmed that Unilabs Middle East has introduced the GlycanAge solution across its healthcare network. The laboratory group conducted its own clinical evaluation before introducing the test to affiliated medical centers. The rollout includes dedicated training, clinical education, and engagement programs for regional healthcare providers.
Neither organization disclosed transaction terms, capital commitments, or anticipated patient testing volumes. A separate digital mental-health platform named Takalam was also named, with Unilabs working with it on a mental-health and wellbeing offering.
Inside the Agreement
The partnership focuses on commercial adoption and technical integration rather than clinical trial discovery. Trade coverage published on 2 October 2026 by healthcaremea.com emphasized that introducing biological-age tests into a health network does not replace conventional medical pathology. The announcement attributes remarks to Basma Ahmed AlBadi AlDhaheri of Hub71 and Salah Bahri of Unilabs Middle East regarding regional technology adoption.
GlycanAge participates directly in the Hub71 ecosystem as a member company. Under the framework, Unilabs works with participating businesses on commercial proofs of concept and regional distribution pathways. For patients in Abu Dhabi, this structure positions the IgG glycan test through a lab network rather than a postal consumer channel.
The short version
What Changes When a Lab Network Carries the Test
The test chemistry remains identical whether ordered through a clinical provider or purchased directly online. Both channels analyze the exact same chains of sugar molecules attached to circulating blood antibodies. What changes entirely is the clinical delivery model, the professional education supporting the ordering doctor, and the patient consultation workflow.
When an individual orders a test online, the sample kit arrives at home and the lab report returns through an individual web account. In contrast, the network route requires a medical consultation where a licensed physician orders the panel.
A doctor ordering an assay does not make the underlying measurement more accurate. An analytical score carries the same technical precision regardless of who purchases the collection vial. The difference lies in clinical context and provider interpretation.
The Clinical Route in Practice
Healthcare providers affiliated with Unilabs Middle East receive training and clinical education. Our guide to glycan age test results explained covers how those raw measurements convert into an age score.
The pricing mechanism also separates the clinical route from consumer retail. Direct consumer kits carry fixed retail costs published openly on storefronts. No price is published for the lab-network route.
What It Does Not Change
A clinical distribution agreement does not provide scientific validation or prove improved analytical accuracy for biological age measurements. Commercial distribution deals represent channel expansion rather than peer-reviewed outcome studies. The Unilabs agreement confirms that a major European diagnostics operator agreed to distribute the test across its Middle East facilities.
This announcement does not introduce a brand-new laboratory biomarker. The assay relies on the established GlycanAge profiling method that evaluates antibody sugar structures. It does not provide organ-specific biological age breakdowns, nor does it measure rate-of-aging metrics.
Nothing in this announcement alters test availability or pricing for readers in the United States. In the American market, consumers still access testing through standard direct-to-consumer channels. The development in Abu Dhabi represents a regional geographic expansion rather than a global regulatory clearance.
This network integration does not replace standard medical diagnostic testing. Conventional laboratory diagnostics ordered by a treating physician remain the route for medical evaluation.
Glycans or Methylation, the Question a Clinician Actually Faces
GlycanAge measures immunoglobulin G glycans rather than deoxyribonucleic acid (DNA) methylation patterns or epigenetic rates of biological aging. Glycans are chains of sugar molecules attached to IgG antibodies that play a role in immune function. It does not measure DNA methylation, organ-specific ages, or pace of ageing.
A clinician choosing between the two is choosing between immune profiling and methylation analysis, which measure different biology.
Our breakdown of methylation clock vs immune age sets out what each one measures and what each has been shown to track.
In our GlycanAge review, we emphasise that neither test type should be viewed as an absolute health verdict. Our comparison of the best biological age test options covers how that choice plays out across the products on sale.
What the Test Costs, and What Is Unpublished
GlycanAge sells its consumer test in the United Arab Emirates for 1,850.00 United Arab Emirates dirhams (AED), while the cost of testing through the Unilabs network remains unpublished. We verified this 1,850.00 AED one-off consumer purchase price on 8 October 2026 directly on the official GlycanAge price-and-plans page. The consumer platform also offers recurring subscription plans delivered once every 6 months or once every 12 months.
The Hub71 press release and Unilabs announcements published zero pricing details for the clinical network route.
The published consumer figure gives a baseline for anyone paying out of pocket. Without published clinical fees, patients cannot determine whether accessing the assay through a physician network costs more than buying a kit online. A clinic is the only place that figure can currently be obtained.
What Would Change This Read
Independent clinical outcome data and transparent pricing would alter how this regional laboratory agreement is evaluated. Longitudinal data from Unilabs showing whether clinician-managed glycan testing changes measurable health outcomes would be the first evidence that the clinical route adds something beyond access.
Disclosing standard clinical pricing would also clarify the financial balance for consumers. Disclosing a price for the clinical route would show how it compares to the 1,850.00 AED consumer retail price.
A head-to-head study measuring IgG glycans against a DNA methylation clock in the same people would settle more than either measure can on its own. Our methodology sets out the criteria we apply, and our biological age hub collects the guides behind them.
Sources
- Hub71, "Hub71 and European Diagnostics Leader Unilabs partner to advance healthcare innovation and commercial adoption in Abu Dhabi," press release, September 29, 2026, hub71.com (accessed October 8, 2026). Source of the release date, Unilabs Middle East joining Hub71+ Life Sciences as an anchor market partner, the statement that Unilabs Middle East has introduced GlycanAge's biological-age testing solution across its healthcare network with training and clinical education, the work with startups on integrations and proofs of concept, the named speakers Basma Ahmed AlBadi AlDhaheri and Salah Bahri, the Takalam mental-health partnership, and the absence of any financial terms, prices or patient volumes.
- Healthcare Middle East, October 2, 2026 (accessed October 8, 2026). Independent trade coverage of the partnership, and the source of the observation that introducing biological-age testing into a healthcare network does not mean the technology replaces conventional medical diagnostics.
- GlycanAge, price and plans (checked October 8, 2026). Source of the 1,850.00 AED one-off consumer price in the United Arab Emirates and the 6-month and 12-month subscription cadences.
- GlycanAge, what biological age testing is (accessed October 8, 2026). Source of the description of the test as an analysis of glycans attached to IgG antibodies, and of the fact that it does not measure DNA methylation, organ-specific ages, or pace of ageing.
Frequently Asked Questions
What did Unilabs Middle East announce about GlycanAge?
Unilabs Middle East announced on 29 September 2026 that it has introduced GlycanAge across its healthcare network in Abu Dhabi as part of a partnership with the Hub71+ Life Sciences ecosystem. The laboratory group stated that the rollout followed a clinical evaluation, accompanied by training and clinical education for healthcare providers. No clinical patient volumes or financial transaction terms were disclosed in the announcement.
Is the clinic version of the GlycanAge test different from the home kit?
The underlying laboratory analysis is identical. Both pathways evaluate immunoglobulin G (IgG) glycans from a blood sample to estimate immune-related biological age. What differs is the clinical delivery model: a clinic-ordered test involves a healthcare provider who orders the panel and reviews the findings with the patient, whereas the consumer kit is self-ordered online with results delivered directly through a digital report.
How much does GlycanAge cost in the UAE?
Direct consumer testing through GlycanAge in the United Arab Emirates costs 1,850.00 United Arab Emirates dirhams (AED) for a single purchase, checked on 8 October 2026. The platform also lists subscription options for testing every 6 or 12 months. In contrast, the pricing for testing ordered through the Unilabs Middle East clinical network has not been publicly released.
Does GlycanAge measure DNA methylation?
GlycanAge does not measure deoxyribonucleic acid (DNA) methylation. The test specifically measures chains of sugar molecules attached to immunoglobulin G antibodies in blood serum. Epigenetic methylation clocks measure different biology, whereas GlycanAge analyses IgG glycans and does not measure DNA methylation, organ-specific ages, or pace of ageing.